Predicting disease progression and mortality in prostate cancer using real-world data-driven time-inhomogeneous Markov models
A time-inhomogeneous Markov model using territory-wide electronic medical records from Hong Kong to estimate 10-year disease progression showed strong prediction performance for metastasis-free survival and overall survival, exceeding Cox proportional hazards and random survival forest models.